Literature DB >> 16243864

Developmental delay: when to suspect and how to investigate for an inborn error of metabolism.

M A Cleary1, A Green.   

Abstract

The purpose of this review is to provide a practical guideline on the suspicion and investigation of inborn errors of metabolism (IEMs) as cause of developmental delay. Developmental delay is a common paediatric problem. Inborn errors of metabolism are a rare cause of developmental delay. However, it is important to detect IEMs for several reasons: accurate counselling may be given regarding recurrence risk; metabolic decompensation may be avoided; and specific treatments may be available. Certain clinical situations are more likely to point to an IEM as the cause of developmental delay. This review highlights the risk factors in the history, the important examination findings, and the appropriate biochemical investigation of the child with developmental delay. Following these guidelines makes "missing" an IEM unlikely.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16243864      PMCID: PMC1720165          DOI: 10.1136/adc.2005.072025

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

1.  Erythema induratum of Bazin in an infant.

Authors:  M W Chang; R Lawrence; S J Orlow
Journal:  Pediatrics       Date:  1999-02       Impact factor: 7.124

Review 2.  Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics.

Authors:  C J Curry; R E Stevenson; D Aughton; J Byrne; J C Carey; S Cassidy; C Cunniff; J M Graham; M C Jones; M M Kaback; J Moeschler; G B Schaefer; S Schwartz; J Tarleton; J Opitz
Journal:  Am J Med Genet       Date:  1997-11-12

Review 3.  Management of mucopolysaccharidosis type III.

Authors:  M A Cleary; J E Wraith
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

4.  Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.

Authors:  T H Zytkovicz; E F Fitzgerald; D Marsden; C A Larson; V E Shih; D M Johnson; A W Strauss; A M Comeau; R B Eaton; G F Grady
Journal:  Clin Chem       Date:  2001-11       Impact factor: 8.327

5.  Diagnostic yield of the neurologic assessment of the developmentally delayed child.

Authors:  A Majnemer; M I Shevell
Journal:  J Pediatr       Date:  1995-08       Impact factor: 4.406

6.  Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society.

Authors:  M Shevell; S Ashwal; D Donley; J Flint; M Gingold; D Hirtz; A Majnemer; M Noetzel; R D Sheth
Journal:  Neurology       Date:  2003-02-11       Impact factor: 9.910

7.  Choice of medical investigations for developmental delay: a questionnaire survey.

Authors:  P Gringras
Journal:  Child Care Health Dev       Date:  1998-07       Impact factor: 2.508

  7 in total
  10 in total

Review 1.  Unexplained developmental delay/learning disability: guidelines for best practice protocol for first line assessment and genetic/metabolic/radiological investigations.

Authors:  J J O'Byrne; S A Lynch; E P Treacy; M D King; D R Betts; P D Mayne; F Sharif
Journal:  Ir J Med Sci       Date:  2015-04-21       Impact factor: 1.568

2.  How paediatricians investigate early developmental impairment in the UK: a qualitative descriptive study.

Authors:  Mark Atherton; Anthony R Hart
Journal:  BMC Pediatr       Date:  2022-05-16       Impact factor: 2.567

3.  Cognitive functioning and psychiatric disorders in children with a metabolic disease.

Authors:  Annik Simons; François Eyskens; Ann De Groof; Ellen Van Diest; Dirk Deboutte; Robert Vermeiren
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-03-10       Impact factor: 4.785

4.  Prevalence of Developmental Delay in Apparently Normal Preschool Children in Isfahan,Central Iran.

Authors:  Omid Yaghini; Roya Kelishadi; Mojtaba Keikha; Negar Niknam; Saeid Sadeghi; Efat Najafpour; Mohammadreza Ghazavi
Journal:  Iran J Child Neurol       Date:  2015

5.  Rare inborn errors of metabolism with movement disorders: a case study to evaluate the impact upon quality of life and adaptive functioning.

Authors:  Hendriekje Eggink; Anouk Kuiper; Kathryn J Peall; Maria Fiorella Contarino; Annet M Bosch; Bart Post; Deborah A Sival; Marina A J Tijssen; Tom J de Koning
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

6.  Failure to shorten the diagnostic delay in two ultra-orphan diseases (mucopolysaccharidosis types I and III): potential causes and implications.

Authors:  Gé-Ann Kuiper; Olga L M Meijer; Eveline J Langereis; Frits A Wijburg
Journal:  Orphanet J Rare Dis       Date:  2018-01-08       Impact factor: 4.123

Review 7.  Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and Lipidomics.

Authors:  Israa T Ismail; Megan R Showalter; Oliver Fiehn
Journal:  Metabolites       Date:  2019-10-21

8.  Evaluation of the young children with neurodevelopmental disability: a prospective study at hamadan university of medical sciences clinics.

Authors:  Afshin Fayyazi; Leila Khezrian; Zohreh Kheradmand; Somayeh Damadi; Ali Khajeh
Journal:  Iran J Child Neurol       Date:  2013

Review 9.  Current evidence-based recommendations on investigating children with global developmental delay.

Authors:  Renuka Mithyantha; Rachel Kneen; Emma McCann; Melissa Gladstone
Journal:  Arch Dis Child       Date:  2017-11       Impact factor: 3.791

Review 10.  Autistic feature as a presentation of Inborn Errors of Metabolism.

Authors:  Farzad Ahmadabadi; Hamid Nemati; Amirmohammad Abdolmohammadzadeh; Adel Ahadi
Journal:  Iran J Child Neurol       Date:  2020
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.